HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Monozygotic twins discordant for phacomatosis pigmentovascularis: evidence for the concept of twin spotting.

Abstract
The term phacomatosis pigmentovascularis (PPV) refers to the occurrence of vascular nevi with melanocytic or epidermal nevi. We report on monozygotic twins (MZTs) discordant for phacomatosis cesioflammea (PPV type II) providing evidence for the mechanism of twin spotting in the development of PPV. The affected twin had a nevus flammeus on the right arm and the right maxilla, and a pigmented area on the trunk in keeping with a persistent, aberrant Mongolian spot. The affected twin had bilateral ocular melanocytosis with abnormal scleral pigmentation, iris mamillations, increased pigmentation of the trabecular meshwork, and increased fundal pigmentation and secondary glaucoma. DNA testing confirmed monozygosity. This case of MZTs discordant for PPV supports the hypothesis that PPV results from mosaicism due to a post-zygotic mutational event and the concept of twin spotting.
AuthorsTanya Moutray, Maria Napier, Ayad Shafiq, Alan Fryer, Simon Rankin, Colin E Willoughby
JournalAmerican journal of medical genetics. Part A (Am J Med Genet A) Vol. 152A Issue 3 Pg. 718-20 (Mar 2010) ISSN: 1552-4833 [Electronic] United States
PMID20186807 (Publication Type: Case Reports, Journal Article)
Copyright(c) 2010 Wiley-Liss, Inc.
Topics
  • Diseases in Twins (etiology, genetics, pathology)
  • Eye (blood supply, pathology)
  • Female
  • Humans
  • Melanosis (genetics, pathology)
  • Models, Genetic
  • Mongolian Spot (genetics, pathology)
  • Mosaicism
  • Neurocutaneous Syndromes (etiology, genetics, pathology)
  • Phenotype
  • Pigmentation Disorders (genetics, pathology)
  • Twins, Monozygotic
  • Vascular Malformations (genetics, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: